There were increased levels of liver enzymes such as ALT, AST, ALP, GGT in serum from the NAFLD group and also higher TC and TG levels, while there was a decrease in ALB and HDL compared with the Control group (Table 1). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.